Exhibits
10-K
from 10-K
138 pages
10-K
02/27/25
EX-10.12
from 10-K
13 pages
Geron Corporation Rsu Award Grant Notice
02/27/25
EX-10.13
from 10-K
20 pages
Amended 2018 Inducement Award Plan
02/27/25
EX-10.17
from 10-K
13 pages
Geron Corporation Rsu Award Grant Notice
02/27/25
EX-10.29
from 10-K
12 pages
Employment Agreement
02/27/25
EX-10.33
from 10-K
115 pages
Loan Agreement Dated as of November 1, 2024 Among Geron Corporation (As Borrower and a Credit Party), the Guarantors Signatory Hereto or Otherwise Party Hereto From Time to Time (As Additional Credit Parties), Biopharma Credit PLC (As Collateral Agent), Bpcr Limited Partnership (As a Lender) and Biopharma Credit Investments V (Master) LP
02/27/25
EX-10.34
from 10-K
44 pages
Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private and Confidential. Revenue Participation Right Purchase and Sale Agreement by and Between Geron Corporation and Royalty Pharma Development Funding, LLC Dated as of November 1, 2024
02/27/25
EX-19.1
from 10-K
20 pages
Report furnished to security holders
02/27/25
EX-21.1
from 10-K
2 pages
Subsidiaries of the registrant
02/27/25
EX-23.1
from 10-K
2 pages
Consent of expert or counsel
02/27/25
EX-31.1
from 10-K
2 pages
Management certification of annual or quarterly disclosure
02/27/25
EX-31.2
from 10-K
2 pages
Management certification of annual or quarterly disclosure
02/27/25
EX-32.1
from 10-K
2 pages
Management certification of financial report
02/27/25
EX-32.2
from 10-K
2 pages
Management certification of financial report
02/27/25
